BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 115 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $263,000 | – | 4,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 285,259 | $16,685,000 | 9.76% |
| JW Asset Management, LLC | 73,649 | $4,308,000 | 2.32% |
| THB ASSET MANAGEMENT | 113,485 | $6,637,000 | 0.81% |
| Eversept Partners, LP | 21,900 | $1,280,931 | 0.56% |
| EAM Global Investors LLC | 20,642 | $1,207,000 | 0.49% |
| RICE HALL JAMES & ASSOCIATES, LLC | 181,690 | $10,627,000 | 0.38% |
| Elk Creek Partners, LLC | 114,230 | $6,681,000 | 0.36% |
| ISTHMUS PARTNERS, LLC | 19,525 | $1,142,000 | 0.29% |
| PURA VIDA INVESTMENTS, LLC | 20,160 | $1,179,000 | 0.25% |
| CADENCE CAPITAL MANAGEMENT LLC | 49,363 | $2,887,000 | 0.16% |